Sinopharm
1099.HK
#2058
Rank
โ‚น634.59 B
Marketcap
โ‚น203.35
Share price
0.76%
Change (1 day)
-6.16%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): โ‚น197.04 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น84.39 Billion. a decrease over its 2022 earnings that were of โ‚น273.12 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 โ‚น271.12 B-0.73%
2022 โ‚น273.12 B-1.72%
2021โ‚น277.89 B11.7%
2020โ‚น248.77 B18.44%
2019โ‚น210.04 B10.85%
2018โ‚น189.48 B3.05%
2017โ‚น183.88 B36.48%
2016โ‚น134.73 B7.11%
2015โ‚น125.78 B12.38%
2014โ‚น111.93 B25.05%
2013โ‚น89.51 B22.54%
2012โ‚น73.05 B35.43%
2011โ‚น53.93 B52.24%
2010โ‚น35.42 B30.99%
2009โ‚น27.04 B60.59%
2008โ‚น16.84 B48.29%
2007โ‚น11.35 B123.29%
2006โ‚น5.08 B